Stratpharma’s Post

Physician Burnout, Direct Pay, and Patient Care in Dermatology 🌱🩺 Physician burnout is soaring, driving many to leave their roles, putting pressure on mid-level providers, and impacting patient care. Amid dwindling insurance reimbursements, and rising living costs, physicians grapple with heavy patient loads, complex documentation, and regulations. The result? Less quality time with patients, delayed appointments, and compromised experiences. 😓❌ Is there a unifying solution? No. We have chosen the direct pay model trying to break free from insurance constraints and regain control enhancing patient experiences. It's a shift that means more time per patient for comprehensive evaluations, meaningful interactions, and ultimately, improved outcomes. 🌟⏱️ However, embracing the direct pay model comes with its hurdles. Transitioning patients can trigger resistance, often due to cost concerns. While it might seem pricier initially, the long-term benefits are undeniable. It's a balance between patient volume and prioritizing top-notch care. ⚖️💼 In our dermatology practice, the direct pay model has been both a blessing and a battle. Two months in, we're witnessing the ease of delivering personalized care, while also facing the uphill task of educating patients about its advantages. 🌿🏥 If this resonates, know you're not alone. Many physicians are embracing direct pay to fight burnout and elevate care quality. By sharing experiences, we can find collective solutions. 🤝📚 Ultimately, the battle against burnout and declining patient care is real. The direct pay model offers hope, empowering physicians to deliver exceptional care while reshaping the patient experience. Challenges persist, but with shared insights and collaboration, we can pave the way to a brighter, patient-centric healthcare landscape. 🌈💙 #PhysicianBurnout #DirectPayModel #PatientCare #Dermatology #boardcertifieddermatologist https://lnkd.in/e4F2NXKf

Reflections on the 13th Meeting of European Hidradenitis Suppurativa Foundation e.V. (#EHSF2024) Prof Falk Bechara (Head of the Department of Dermatologic Surgery, and Senior Physician of the Department of Dermatology, Allergology and Venereology at the Ruhr-University Bochum, Germany) and I met to discuss some highlights from the recent #hidradenitissuppurativa (HS) #research conference in Lyon, France. We discuss, among other things: - Updates to the European HS treatment guidelines - #stigma experienced by people with HS in #healthcare interactions - The rapidly increasing number of HS #research #publications - The role of #patient #organizations Dr Stephanie Goldberg (HS surgeon and Vice President for Graduate Medical Education at Mary Washington Healthcare in Fredericksburg, Virginia, USA) reflects on measures to assess the #efficacy of any HS #treatment. Insights are also shared on: - patient and #physican preferences for HS treatments, - the window of opportunity for successful treatment, and - the importance of including both #clinician- and #patient-reported outcome measures. Please visit: https://lnkd.in/eS6GUmpV for more.

Curious to see what our clients have to say about our Pathpoint eDerma platform? Mr. Ken McAlister from East Lancashire Hospitals NHS Trust shares his thoughts on how eDerma will cut waiting times for suspected skin cancer patients and optimise demand management in acute dermatology departments across the Lancashire and South Cumbria Integrated Care Board (ICB). Don’t just take our word for it; read Mr. McAlister's testimonial below! #testimonial #quote #skincancercare #healthcare #healthcaretechnology #healthcareinnovation #innovationinhealthcare #healthtech #digitalhealth #digitalsolutions #digitaltransformation #clienttestimonial

Join PDS CEO Russell Hendrickson and Scott Everitt MBA, VP of Healthcare Solutions, on Tuesday, June 11, when they present 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗞𝗲𝘆 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗜𝗻𝗱𝗶𝗰𝗮𝘁𝗼𝗿𝘀 (𝗞𝗣𝗜𝘀) for #healthcareprofessionals at 11 AM ET NYC. Save a seat: https://bit.ly/3PVb2X2 Explore case studies showcasing organizations that calculate multiple sets of RVU values per year for productivity benchmarks, contracting, or compensation. We'll also spotlight specialty-specific KPIs, particularly focusing on areas like dermatology, orthopedics, ophthalmology, and allergy. What You'll Learn: ● The importance of crafting essential KPIs tailored to your organization's unique goals and challenges ● Strategies for evaluating and enhancing your current KPIs to yield more robust insights ● The necessity of specialty-specific KPIs that are often absent in many traditional reporting systems ● Best practices for seamlessly integrating your custom KPIs into your existing data analytics framework for peak performance Who Should Attend: Healthcare administrators, IT professionals, performance analysts, specialty-focused practitioners, and anyone passionate about harnessing the power of custom KPIs to enhance healthcare outcomes will find this session invaluable. Learn more: https://bit.ly/3PVb2X2 #practicaldatasolutions #PDSAnalytics #datadriven #healthcareKPIs #patients #returningpatients #RVU #KPIs #customizedKPIs #healthcareadministration #specialtyfocused #healthcarebenchmarks #benchmark #DataDrivenAnalytics #healthcareanalytics #performanceanalysts #practicemanagers #Dermatology, #Orthopedics, #Ophthalmology #Allergy.

Join PDS tomorrow at 11 AM ET to explore Data-Driven Analytics: Customized KPIs. https://bit.ly/3PVb2X2 #PDSAnalytics #datadriven #healthcareKPIs #patients #returningpatients #RVU #KPIs #customizedKPIs #healthcareadministration #specialtyfocused #healthcarebenchmarks #benchmark #DataDrivenAnalytics #healthcareanalytics #performanceanalysts #practicemanagers #Dermatology, #Orthopedics, #Ophthalmology #Allergy

Tune into Dermbusters! Join me as I chat with colleagues about the most common misperceptions heard in dermatology, and get tips on how to bust these myths for your patients! On this episode Dr. Lisa Swanson discusses -Are monthly labs for Accutane needed for safety?  -Does Accutane increase the risk of suicidal behavior or depression? https://lnkd.in/gPfe3uAG

Day 1 ✅ After doing my IP last year I guess minor illness was a natural progression and so glad I chose One PCN Training. No matter how experienced or inexperienced you are this is tailored to everyone’s needs with discussion of real life case scenarios. A real good mix of clinicians present which allowed for some very useful conversations on best practice as knowing the guideline vs being able to put the guideline in practice are two different things. For anyone thinking about holding minor illness clinics I would recommend you making the leap and getting this under your belt. This will ensure you practice safely evidence based and contribute to ensuring patients are getting the care they deserve.

We’re excited to invite you to an exclusive webinar: Your 2024 OBGYN Marketing Plan: The Path to Becoming a Leader in Women’s Health Date: February 8th, 2024 at 8pm Eastern / 5pm Pacific Why Attend? - Discover how to stand out as a leader in gynecology by offering advanced treatments like the Sonata procedure for fibroids and other minimally invasive gynecological surgeries. - Gain insights into social media strategies, Local SEO, and the power of Google reviews in attracting and retaining patients. - Learn how to target women in your area who may have heavy periods or fibroids but haven’t sought treatment yet = new patients for your practice. - Explore the impact of email marketing to your current patient list and how hosting educational webinars can inform patients about new advancements in women’s health. Webinar Highlights: - Strategies for getting your name out there as a specialist in GYN surgery and women’s health. - Tips for communicating your advanced training to both potential and existing patients. - Real-world examples of OBGYNs who have successfully elevated their practices. - Q&A session with experts from Gynesonics and Medical Marketing Whiz. How to Register: https://lnkd.in/g8exbkF2 Don’t miss this opportunity to elevate your practice and make a significant impact on women’s health in your community. Join us on February 8th to gain valuable insights that will set you apart as a leading OBGYN in your area. We look forward to your participation. #obgynmarketing #intimatewellness #functionalmedicinemarketing #medicalmarketing #obgyn #functionalmedicine #gynecology #dermatology #biote #monalisatouch #coretintima #femtouch #womenshealth #viveve #votiva #cliovana #emsella #medicalspamarketing #medicalpracticemarketing #medicaldevicemarketing #medicaldigitalmarketing #medicalcontentmarketing #medicalmarketingagency #medicalmarketingtips #medicalmarketingadvice #medicalmarketing101 #medicalmarketingpros #Sonata #Gynesonics #GYNMarketing

👧🌟 Advancing Pediatric Dermatology Care! 💼💡 Exciting news from a retrospective case-series study by Dr Kenshi Yamasaki from ohoku University School of Medicine, Japan: Oral Clarithromycin Therapy for Perioral Dermatitis in Children. 📈 These findings offer valuable insights into an effective treatment approach for this common pediatric dermatological condition. 🔖 Read more at https://lnkd.in/dWQUm8za. #PediatricDermatology #DermatologyResearch #PerioralDermatitis #Clarithromycin

A rare case of periorbital nasal dermoid cyst 🪩 A 25-year-old man was referred to our ORL-HNS clinic due to nasal root mass with extention to right medial canthus (Fig A, red arrows). 🪩 On his HRCT scan there was a hypodense and well-defined mass at the base of right nasal bone and naso-frontal suture (Fig. B, yellow circle and arrow) with obvious smooth erosion (Fig. B, red arrows). No intracranial extension was identified. 🪩 At the theater the mass was removed in an enbloc manner with no adhesions to the adjacent tissues (Fig. C- black and white due to LinkedIn protocols). 🪩 For prevention of a hollowed out appearance due to adjacent bone erosions the tumor space was filled with crashed mineralized bone allograft (Fig. D, graft cubes showed by red arrows). 🔴 Final pathology report was a cyst lined by keratinized squamous epithelium consistent with dermoid cyst. 📚 Dermoid cysts are developmental choristoma originating from aberrant ectodermal tissue, usually develop between 3 to 5 weeks of gestation. It is an embryonic displacement of epidermis to a subcutaneous location along embryonic lines of closure. They are typically located at the points of fusion of zygomaticofrontal and frontoethmoidal sutures. Hence they are commonly seen along the lateral third of eyebrow or supraorbital ridge. 📚 Clinically, they present initially as dormant lesions, later as a slowly enlarging, unilateral, painless, firm mass with proptosis, occasionally with motility restriction, and decreased vision. Imaging shows round, well-defined lesions with an enhancing rim that may contain calcium and a lucent center. Complete surgical excision in to be the treatment of choice. The prognosis is excellent, but recurrences with infiltration may follow incomplete excision or rupture of the capsule. Reference: 1.Cummings otolaryngology reference textbook 2. https://lnkd.in/dSGiJ9-W #otorhinolaryngology #otolaryngology #otolarygologia #drarjman #tumor #ent